FENNEC PHARMACEUTICALS INC (FRX.CA) Stock Balance Sheet
TSX:FRX - Toronto Stock Exchange - CA31447P1009 - Common Stock - Currency: CAD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 1.34M | N/A | N/A | N/A | |||
| Cash Equivalents | 24.61M | 11.93M | 23.77M | 21.10M | 30.34M | |||
| Receivables | 12.88M | 8.81M | 1.55M | N/A | N/A | |||
| Inventories | 1.06M | 2.16M | 580.00K | N/A | N/A | |||
| Other Current Assets | 3.55M | 2.62M | 830.00K | 1.28M | 1.08M | |||
| Total Current Assets | 44.12M | 26.86M | 26.73M | 22.39M | 31.42M | |||
| Non-Current Assets | ||||||||
| Other Non-Current Assets | 822.00K | 6.00K | 210.00K | 30.00K | 0.00 | |||
| Total Non-Current Assets | 822.00K | 6.00K | 210.00K | 20.00K | 0.00 | |||
| TOTAL ASSETS | 44.95M | 26.86M | 26.94M | 22.41M | 31.42M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.43M | 3.77M | 2.22M | 880.00K | 780.00K | |||
| Accounts Payable | 3.24M | 3.78M | 2.39M | 780.00K | 1.57M | |||
| Other Current Liabilities | 248.00K | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 6.92M | 7.55M | 4.61M | 1.65M | 2.35M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 18.21M | 30.00M | 25.00M | 5.00M | 0.00 | |||
| Other Non-Current Liabilities | 25.69M | 933.00K | -100.00K | -10.00K | N/A | |||
| Total Non-Current Liabilities | 43.90M | 30.93M | 24.90M | 4.99M | 0.00 | |||
| TOTAL LIABILITIES | 50.82M | 38.49M | 29.51M | 6.64M | 2.35M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -219.68M | -219.25M | -203.20M | -179.49M | -162.14M | |||
| Additional Paid In Capital | 66.96M | 62.07M | 56.80M | 53.21M | 49.23M | |||
| Common Shares | 145.61M | 144.31M | 142.59M | 140.80M | 140.73M | |||
| Other Shareholders' Equity | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | |||
| Shares Outstanding | 27.53M | 27.03M | 26.36M | 26.01M | 26.00M | |||
| Tangible Book Value per Share | -0.21 | -0.43 | -0.10 | 0.61 | 1.12 | |||
| Total Shareholders' Equity | -5.87M | -11.62M | -2.57M | 15.77M | 29.07M | |||
| TOTAL LIABILITIES AND EQUITY | 44.95M | 26.86M | 26.94M | 22.41M | 31.42M | |||
| Statistics | ||||||||
| Debt/Equity | -3.10 | -2.58 | -9.73 | 0.32 | N/A | |||
| Current Ratio | 6.38 | 3.56 | 5.80 | 13.57 | 13.37 | |||
| Return On Assets (ROA) | -0.97% | -59.73% | -88.01% | -77.42% | -57.64% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -110.02% | -62.30% | |||
| Return On Invested Capital (ROIC) | 4.86% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 13.78% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 13.78% | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.28